Area of research
Hematology · Molecular Biology
Research interest
Research interests include Cancer research, Cell growth, Neuroinflammation, Neuroscience, Chemistry, and Western blot.
Microglial TAK1 promotes neurotoxic astrocytes and cognitive impairment in LPS-induced hippocampal neuroinflammation
The membrane receptor CD44: roles in neurodegenerative diseases
TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis
HSPA4 restrains transferrin in dopaminergic neurons to attenuate ferroptosis in a Parkinson’s disease model
SIRT1 improves lactate homeostasis in the brain to alleviate parkinsonism via deacetylation and inhibition of PKM2
Efficacy and Safety of Zanubrutinib Monotherapy in Real-World Chinese CLL/SLL Patients
Bufalin suppresses esophageal squamous cell carcinoma progression by activating the PIAS3/STAT3 signaling pathway
CD44 deficiency represses neuroinflammation and rescues dopaminergic neurons in a mouse model of Parkinson’s disease
Single-cell RNA sequencing reveals dysregulation of spinal cord cell types in a severe spinal muscular atrophy mouse model
TAK1 Phosphorylates RASSF9 and Inhibits Esophageal Squamous Tumor Cell Proliferation by Targeting the RAS/MEK/ERK Axis
RASSF9 promotes NSCLC cell proliferation by activating the MEK/ERK axis
CtBP2 interacts with TGIF to promote the progression of esophageal squamous cell cancer through the Wnt/β‑catenin pathway
Silencing TLR4/MyD88/NF-κB Signaling Pathway Alleviated Inflammation of Corneal Epithelial Cells Infected by ISE
miR-203a-3p regulates the cellular processes of esophageal cancer cells via targeting CtBP2
Correlation between sex and efficacy of immune checkpoint inhibitors (<scp>PD</scp>‐1 and <scp>CTLA</scp>‐4 inhibitors)
EphA2 chimeric antigen receptor-modified T cells for the immunotherapy of esophageal squamous cell carcinoma
Long non-coding RNA DANCR promotes cell proliferation, migration, invasion and resistance to apoptosis in esophageal cancer
C-terminal binding protein‑2 mediates cisplatin chemoresistance in esophageal cancer cells via the inhibition of apoptosis
The effectiveness of PD-1 inhibitors in non-small cell lung cancer (NSCLC) patients of different ages